747 related articles for article (PubMed ID: 18462260)
1. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
2. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
3. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
5. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
[TBL] [Abstract][Full Text] [Related]
6. The heart: an end-organ of GH action.
Colao A; Vitale G; Pivonello R; Ciccarelli A; Di Somma C; Lombardi G
Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S93-101. PubMed ID: 15339252
[TBL] [Abstract][Full Text] [Related]
7. The cardiovascular system in growth hormone excess and growth hormone deficiency.
Lombardi G; Di Somma C; Grasso LF; Savanelli MC; Colao A; Pivonello R
J Endocrinol Invest; 2012 Dec; 35(11):1021-9. PubMed ID: 23143695
[TBL] [Abstract][Full Text] [Related]
8. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
9. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
Colao A
Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular complications in acromegaly.
Vitale G; Pivonello R; Lombardi G; Colao A
Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
[TBL] [Abstract][Full Text] [Related]
12. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
14. Does growth hormone play a role in chronic heart failure?
Volterrani M; Giustina A; Lorusso R; Giordano A
Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
[TBL] [Abstract][Full Text] [Related]
15. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
16. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology.
Graham MR; Evans P; Thomas NE; Davies B; Baker JS
Am J Cardiovasc Drugs; 2009; 9(6):371-81. PubMed ID: 19929035
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
18. [Heart disease in acromegaly. Study of 27 patients].
Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F
Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234
[TBL] [Abstract][Full Text] [Related]
19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
20. Cardiological aspects of growth hormone and insulin-like growth factor-I.
Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
